anti-cancer biosimilar
Scope
Date
~
-
Bio & Pharma
Samsung Bioepis sees greater market for Byooviz eye disease biosimilar
NEW YORK – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is one step ahead of its rivals in t...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis’ SB12 shows same clinical effects as Alexion’s Soliris
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...
Jun 14, 2022 (Gmt+09:00)
language -
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion to sell biosimilar products via its own channel in Europe
South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...
May 11, 2022 (Gmt+09:00)
-
Bio & Pharma
FutureChem seeks FDA nod for prostate cancer radiopharma trials
FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...
Apr 20, 2022 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 anti-tank missile in spotlight amid Ukraine war
An anti-tank guided weapon produced by South Korean defense exporter LIG Nex1 Co. is in the spotlight as Ukraine said its forces destroyed Russian a...
Apr 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Pharmaceuticals
Samsung Bioepis to double biosimilars, may resume Nasdaq listing plans
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, plans to double the number of its biosimilar products on sale to 10 by 2025 and acce...
Feb 24, 2022 (Gmt+09:00)
-
Pharmaceuticals
Samsung Bioepis posts $1.26 billion in global biosimilar sales
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said on Friday that sales of its five biosimilar products in global markets, excludi...
Feb 18, 2022 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Biotech
JW Bioscience in pancreatic cancer biomarker deal with Immunovia
JW Bioscience Co., a subsidiary of South Korea’s JW Life Science Co., has signed a non-exclusive agreement to transfer its patented technology...
Sep 15, 2021 (Gmt+09:00)
language -
Tech, Media & Telecom
S.Korea fines Google $180 mn for operating system market abuse
South Korea's Fair Trade Commission (FTC) on Tuesday imposed a fine of 207.4 billion won ($180 million) on Google, alongside a correction order, aft...
Sep 14, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Biosimilars
Samsung Bioepis gets nod for sale of ophthalmology biosimilar in Europe
South Korea’s biopharmaceutical company Samsung Bioepis Co. won approval from European authorities for sale of Byooviz, its ophthalmology bios...
Aug 23, 2021 (Gmt+09:00)
language -
Biotech
IMB Dx eyes platform to detect stage 1 cancer with single draw of blood
IMB Dx Inc., a South Korean biotechnology startup focusing on diagnostic devices, plans to develop a platform that can detect early-stage cancer wit...
Jul 22, 2021 (Gmt+09:00)
-
Biosimilars
Korean drugmakers race to release Stelara biosimilars
South Korea’s major drugmakers such as Celltrion Inc., Samsung Bioepis and Dong-A St are going for broke to release biosimilars of Stelara, Jo...
Jul 22, 2021 (Gmt+09:00)
language -
Biosimilars
Celltrion, Samsung Bioepis anticipate increased biosimilar sales in Europe
South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...
Jul 12, 2021 (Gmt+09:00)
-
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
IPOs
HK inno.N poised to bolster S.Korea's IPO lineup in H2
HK inno.N Corp., a pharmaceuticals unit of South Korea's Kolmar Korea, is set to go public in early August at a valuation of around 2 trillion won (...
Jun 29, 2021 (Gmt+09:00)
-
Automobiles
US anti-dumping duties add to Korean tire makers' woes
The US trade body’s approval of anti-dumping tariffs on tire imports from South Korea, Taiwan and Thailand is adding to the woes of Korea&rsqu...
Jun 24, 2021 (Gmt+09:00)
language -
Automobiles
Tennessee mayors oppose ITC’s anti-dumping duties on Hankook Tire
Politicians in the US state of Tennessee are urging the International Trade Commission (ITC) to avoid hurting the operations of Hankook Tire & T...
Jun 14, 2021 (Gmt+09:00)
-
Tech, Media & Telecom
LS Cable develops anti-hacking optical cables
LS Cable & System Ltd., South Korea's leading wire and cable manufacturer, has developed a new optical cable that can help ward against data breac...
Nov 03, 2020 (Gmt+09:00)